Overview
Kazuhiko Namekata practices in Tokyo, Japan. Namekata is rated as a Distinguished expert by MediFind in the treatment of Glaucoma. Their top areas of expertise are Ganglion Cyst, Glaucoma, Ocular Hypertension (OHT), and Late-Onset Retinal Degeneration.
Their clinical research consists of co-authoring 62 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 30 articles in the study of Glaucoma.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Ganglion CystNamekata isDistinguished. Learn about Ganglion Cyst.
- GlaucomaNamekata isDistinguished. Learn about Glaucoma.
- Ocular Hypertension (OHT)Namekata isDistinguished. Learn about Ocular Hypertension (OHT).
- Experienced
- CACH SyndromeNamekata isExperienced. Learn about CACH Syndrome.
- Diabetic RetinopathyNamekata isExperienced. Learn about Diabetic Retinopathy.
- HypotoniaNamekata isExperienced. Learn about Hypotonia.
- Late-Onset Retinal DegenerationNamekata isExperienced. Learn about Late-Onset Retinal Degeneration.
- Multiple Sclerosis (MS)Namekata isExperienced. Learn about Multiple Sclerosis (MS).
- Optic NeuritisNamekata isExperienced. Learn about Optic Neuritis.